CL
DMII

CSS LLC’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

CSS LLC’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-110,042
Closed -$1.1M – 1231
2026
Q1 		$1.1M Sell
110,042
-695,959
-86% -$6.93M 0.05% 306
2025
Q4 		$7.98M Buy
+806,001
New +$7.97M 0.35% 54

Other funds holding DMII

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

CSS LLC's DMII Position: Q2 2026 in Review

CSS LLC sold out of Drugs Made In America Acquisition II Corp (DMII) in Q2 2026, closing a stake of 110,042 shares — an estimated $1.1M sold.

CSS LLC first reported a position in DMII in Q4 2025 and held it in 2 quarters. The position peaked at $7.98M in Q4 2025. 68 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • CSS LLC reported no remaining Drugs Made In America Acquisition II Corp position as of Q2 2026 after selling out during the quarter.
  • CSS LLC sold 110,042 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $1.1M.
  • CSS LLC first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and held it in 2 quarters.
  • CSS LLC's Drugs Made In America Acquisition II Corp position peaked at $7.98M in Q4 2025.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.